Literature DB >> 8634983

Screening. The next century.

R M Richart1.   

Abstract

BACKGROUND: Screening for cervical cancer and its precursors has traditionally been performed by Papanicolaou smear. As cost considerations have become more important and as developing countries have begun to initiate screening programs, other approaches to screening have been considered.
METHODS: Proposed new methods potentially useful for screening for cervical cancer and its precursors were reviewed.
RESULTS: Cervical cancer screening using unaided or aided visual approaches, human papillomavirus DNA testing and typing, cervical photography, and automated Pap smear screening instruments are all potentially valuable when used alone or in combination, depending on the country.
CONCLUSIONS: New techniques will make it possible to screen high risk, low-income populations for cervical cancer and its precursors and to do so more cost-effectively than is possible using conventional Western approaches. In addition, the latest technology can enhance the screening methods traditionally used in industrialized countries and can increase the positive and negative predictive value of the screening method.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8634983     DOI: 10.1002/1097-0142(19951115)76:10+<1919::aid-cncr2820761308>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

1.  A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings.

Authors:  M V Jacobs; P J Snijders; A J van den Brule; T J Helmerhorst; C J Meijer; J M Walboomers
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

2.  Cells and the (imaginary) patient: the multistable practitioner-technology-cell interface in the cytology laboratory.

Authors:  Anette Forss
Journal:  Med Health Care Philos       Date:  2012-08

3.  Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus.

Authors:  B Kleter; L J van Doorn; L Schrauwen; A Molijn; S Sastrowijoto; J ter Schegget; J Lindeman; B ter Harmsel; M Burger; W Quint
Journal:  J Clin Microbiol       Date:  1999-08       Impact factor: 5.948

4.  Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.

Authors:  Groesbeck P Parham; Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Andrew O Westfall; Kristin E King; Carla Chibwesha; Krista S Pfaendler; Gracilia Mkumba; Victor Mudenda; Sharon Kapambwe; Sten H Vermund; Michael L Hicks; Jeffrey Sa Stringer; Benjamin H Chi
Journal:  HIV Ther       Date:  2010

5.  Detection and typing of human papillomavirus by e6 nested multiplex PCR.

Authors:  K Sotlar; D Diemer; A Dethleffs; Y Hack; A Stubner; N Vollmer; S Menton; M Menton; K Dietz; D Wallwiener; R Kandolf; B Bültmann
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

6.  Gelsolin and ceruloplasmin as potential predictive biomarkers for cervical cancer by 2D-DIGE proteomics analysis.

Authors:  Ilambarthi Lokamani; Mee-Lee Looi; Siti Aishah Md Ali; Ahmad Zailani Hatta Mohd Dali; Muhammad Azrif Ahmad Annuar; Rahman Jamal
Journal:  Pathol Oncol Res       Date:  2013-08-08       Impact factor: 3.201

Review 7.  Clinical implications of microRNAs in cancer.

Authors:  L C Bovell; B D K Putcha; T Samuel; U Manne
Journal:  Biotech Histochem       Date:  2013-05-07       Impact factor: 1.718

8.  Cervical cancer prevention program in Jakarta, Indonesia: See and Treat model in developing country.

Authors:  Laila Nuranna; Mohamad Farid Aziz; Santoso Cornain; Gatot Purwoto; Sigit Purbadi; Setyawati Budiningsih; Budiningsih Siregar; Alexander Arnold Willem Peters
Journal:  J Gynecol Oncol       Date:  2012-07-02       Impact factor: 4.401

9.  Prediction of high-grade cervical intraepithelial neoplasia in cytologically normal women by human papillomavirus testing.

Authors:  F Carozzi; G Ronco; M Confortini; D Noferini; C Maddau; S Ciatto; N Segnan
Journal:  Br J Cancer       Date:  2000-12       Impact factor: 7.640

10.  "Saving lives": Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria.

Authors:  Katharina T Paul
Journal:  Soc Sci Med       Date:  2016-02-06       Impact factor: 4.634

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.